ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

223
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
bullishOlympus Corp
25 Jun 2020 16:27

Olympus Finally Sells Its Loss-Making Camera Business

Olympus announced yesterday (24th June) that it will be selling its Imaging business to Japan Industrial Partners (JIP) and the parties are aiming...

Share
24 Jun 2020 13:40

Taisho Pharma Seems the Best Suitor for Takeda’s Japan OTC Business

It was reported by several news media outlets that Blackstone, Bain Capital, CVC Capital Partners and Taisho Pharmaceutical are among the final...

Share
22 Jun 2020 06:42

🇯🇵 JAPAN - Stress Tests Part 3 - Inventory, Fixed Asset & Free Cash Flows

FROM OPERATING TO FINANCING CASH FLOWS -  Having examined Operating Cash Flow in our previous Insight, we shall look into the 'stressors' between...

Logo
313 Views
Share
12 Jun 2020 16:26

Takeda Offloads Asia-Focused Drugs to South Korea’s Celltrion

The Japanese drug maker, Takeda Pharmaceutical (4502 JP)  announced yesterday (11th June 2020) that it has entered into an agreement to divest a...

Share
18 May 2020 17:28

Japan Proxy Season - Power to the People

Shareholders are the owners, and owners have the power. I doubt that John Lennon would have written a song about shareholders, but if he had, that...

Logo
167 Views
Share
x